News

2019

company

year

domain

New Publication in Cancer Research Highlights Discovery of SY-1365, a First-in-Class Selective CDK7 Inhibitor, and its Promise as a Potentially Transformative Targeted Approach for Difficult-to-Treat Cancers

Syros Pharmaceuticals 05.07.2019

MIT Solve Announces Launch of Solve Innovation Fund

Flagship Pioneering 05.07.2019

TARIS Bio Initiates New Clinical Study of TAR-302 in Overactive Bladder

TARIS Biomedical 05.01.2019

Kintai’s Host-Targeting Niche in Flagship Microbiome Ecosystem

04.16.2019

Flagship Unveils Gut-Focused Upstart Kintai, with Former GSK Exec as Chief

04.16.2019

Flagship Pioneering Unveils Kintai Therapeutics and Appoints Pharmaceutical Drug Developer Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer

Flagship Pioneering 04.16.2019

KSQ Therapeutics Announces Appointment of Douglas Pagán as Chief Financial Officer

KSQ Therapeutics 04.16.2019

KSQ Therapeutics Announces Appointment Of Beni B. Wolf, MD, PhD, As Chief Medical Officer

KSQ Therapeutics 04.16.2019

Kaleido Biosciences Announces Key Appointments to Leadership Team

04.08.2019

Rubius Therapeutics Announces Extensive Preclinical Data for Three Red Cell Therapeutic Oncology Programs at the 2019 American Association for Cancer Research Annual Meeting

04.02.2019

Loading